Enhanced plasmid DNA delivery using anionic LPDII by listeriolysin O incorporation

Journal of Gene Medicine

Volumn 7, Issue 8, 2005, Pages 1077-1085

  Lorenzi, Gretchen L ^a,b   Lee, Kyung Dall ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE   (United States)

Author keywords

DNA delivery; Liposome; Listeriolysin O; LPDII; Protamine

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOFECTAMINE; LIPOSOME; LISTERIOLYSIN; LUCIFERASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PLASMID DNA; PROTAMINE SULFATE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENCAPSULATION; ENDOSOME; GENE TARGETING; GENETIC TRANSFECTION; LEUKEMIA CELL LINE; LIPID COMPOSITION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REPORTER GENE;

ANIMALS; ANIONS; BACTERIAL TOXINS; DNA; DRUG CARRIERS; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; LIPOSOMES; MICE; PLASMIDS; PROTAMINES; SERUM; TRANSFECTION;

EID: 23944493041     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.750     Document Type: Article

References (28)

1. Christ M. Preclinical evaluation of gene transfer products: safety and immunological aspects. Toxicology 2002; 174: 13-19.
2. Robbins PD, Tahara H, Ghivizzani SC. Viral vectors for gene therapy. Trends Biotechnol 1998; 16: 35-40.
3. Ledley F. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
4. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
5. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-358.
6. Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 2001; 46: 187-203.
7. Wagner E. Application of membrane-active peptides for nonviral gene delivery. Adv Drug Deliv Rev 1999; 38: 279-289.
8. Larson GM, Lee K-D. Macromolecular cytosolic delivery: cell membranes as the primary obstacle. Arch Pharm Res 1998; 21: 621-628.
9. Gottschalk S, Tweten R, Smith L, et al. Efficient gene delivery and expression in mammalian cells using DNA coupled with perfringolysin O. Gene Ther 1995; 2: 498-503.
10. Lee R, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481-8487.
11. Lee K-D, Oh Y, Portnoy D, et al. Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J Biol Chem 1996; 271: 7249-7252.
12. Dramsi S, Cossart P. Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite. J Cell Biol 2002; 156: 943-946.
13. Bielecki J, Youngman P, Connelly P, et al. Bacillus subtilis expressing a hemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 1990; 345: 175-176.
14. Mandal M, Lee KD. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochim Biophys Acta 2002; 1563: 7-17.
15. Mathew E, Hardee GE, Bennett CF, et al. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Ther 2003; 10: 1105-1115.
16. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 1997; 4: 891-900.
17. Litzinger DC, Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim Biophys Acta 1992; 1113: 201-227.
18. Gedde MM, Higgins DE, Tilney LG, et al. Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes. Infect Immunol 2000; 68: 999-1003.
19. Saito G, Amidon GL, Lee KD. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther 2003; 10: 72-83.
20. Papahadjopoulos D, Allen TM, Gabizon A, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11 460-11 464.
21. Drummond DC, Meyer O, Hong K, et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999; 51: 691-743.
22. Tighe H, Corr M, Roman M, et al. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 1998; 19: 89-97.
23. Straubinger RM. pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells. Methods Enzymol 1993; 221: 361-376.
24. Düzgünes N, Straubinger RM, Baldwin PA, et al. Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry 1985; 24: 3091-3098.
25. Connor J, Huang L. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J Cell Biol 1985; 101: 582-589.
26. Reimer D, Zhang Y, Kong S, et al. Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. Biochemistry 1995; 34: 12 877-12 883.
27. Ahsan F, Rivas IP, Khan MA, et al. Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. J Control Release 2002; 79: 29-40.
28. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 1997; 4: 961-968.